The second year under pandemic conditions draws to its end. We all had high hopes when the vaccination campaign started in early 2021. Unfortunately the virus has still more arrows in its quiver than anybody expected. Nevertheless, we can look back on a successful 30th anniversary year.
Our subsidiary DiaSys Japan proudly celebrates its 15th anniversary this year! CEO Yoshihiko Akagi gives us a glimpse into the history of DiaSys Japan.
DiaSys' immunoassay developer Thomas Masetto was invited to speak at the Stakeholder Event of the EU-funded (EMPIR) project SEPTIMET and at a EURAMET workshop.